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ABSTRACT
Aim: To evaluate the effect of breastfeeding on long-term (breast carcinoma, ovarian
carcinoma, osteoporosis and type 2 diabetes mellitus) and short-term (lactational
amenorrhoea,postpartumdepression,postpartumweightchange)maternalhealthoutcomes.
Methods: A systematic literature search was conducted in PubMed, Cochrane Library and
CABI databases. Outcome estimates of odds ratios or relative risks or standardised mean
differences were pooled. In cases of heterogeneity, subgroup analysis and meta-regression
were explored.
Results: Breastfeeding >12 months was associated with reduced risk of breast and ovarian
carcinoma by 26% and 37%, respectively. No conclusive evidence of an association
between breastfeeding and bone mineral density was found. Breastfeeding was associated
with 32% lower risk of type 2 diabetes. Exclusive breastfeeding and predominant
breastfeeding were associated with longer duration of amenorrhoea. Shorter duration of
breastfeeding was associated with higher risk of postpartum depression. Evidence
suggesting an association of breastfeeding with postpartum weight change was lacking.
Conclusion: This review supports the hypothesis that breastfeeding is protective against
breast and ovarian carcinoma, and exclusive breastfeeding and predominant breastfeeding
increase the duration of lactational amenorrhoea. There is evidence that breastfeeding
reduces the risk of type 2 diabetes. However, an association between breastfeeding and
bone mineral density or maternal depression or postpartum weight change was not evident.
INTRODUCTION
Breast milk is the natural first food for newborns. It
provides all the energy and nutrients that an infant needs
for the first six months of life, up to half or more during the
second half of infancy and up to one-third during the
second year of life (1,2). For mothers, breastfeeding has
been reported to confer lower risk of breast and ovarian
carcinoma (3,4), greater postpartum weight loss (5) and
decreased blood pressure (6) compared with no breastfeed-
ing. The World Health Organization (WHO) recommends
exclusive breastfeeding in the first six months and contin-
uation of breastfeeding for 2 years and beyond (1).
The association between breastfeeding and breast carci-
noma in mothers has received increased scrutiny in recent
years. A number of studies have suggested that breastfeed-
ing, particularly for an extended period of time, may be
associated with a decreased risk of breast carcinoma, even
after adjustment for potential confounders (7). It is difficult,
however, to estimate the magnitude of association between
breastfeeding duration and breast carcinoma if any, because
of the different methodologies used in breastfeeding his-
Abbreviations
CI, Confidence interval; HIC, High-income country; LMIC, Low-
and middle-income country; MeSH, Medical Subject Heading;
OR, Odds ratio; PPD, Postpartum depression; RCTs, Randomised
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Key Notes
 Longer duration of breastfeeding protects against breast
and ovarian carcinoma.
 Exclusive breastfeeding and predominant breastfeeding
increase the duration of lactational amenorrhoea.
 Evidence on the association between breastfeeding and
maternal bone mineral density, maternal depression or
postpartum weight change was lacking.
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tories. Parity is also a protective factor against breast
carcinoma (8), and there may be an interaction between
parity and breastfeeding duration interplay in protecting
women from breast carcinoma.
Ovarian cancer is one of the most common cancers in
female (9,10). Reproductive factors have been identified as
markers of risk for ovarian cancer. These reproductive
factors mainly include total number of pregnancies, parity,
age at menarche and menopause, as well as breastfeeding
(11). Evidence from previous analyses indicates an inverse
association between breastfeeding and the risk of ovarian
carcinoma (4,12).
Calcium metabolism and bone metabolism are substan-
tially altered with increased calcium demands during
pregnancy and lactation. Bone densities can decrease by
between 3 and 10 per cent in the span of a few months in a
healthy mother (13). Confounders commonly considered in
the studies of the relationship between fracture risk and
breastfeeding are age, hormone replacement therapy, parity
and BMI (4).
Available literature suggests that breastfeeding reduces
the risk of maternal type 2 diabetes in some cohort studies,
but the evidence from published studies has differed with
regard to the strength of the association (14,15).
The literature suggests that exclusive breastfeeding pro-
tects against pregnancy (16,17). Some studies, however,
show that exclusive breastfeeding is not always associated
with inhibition of ovulation (18,19).
The incidence of postpartum depression (PPD) is high
(10–15%) (20), and depression during pregnancy usually
continues into the postpartum period (21). Postpartum
depression has an immediate impact on mothers. It carries
long-term risks for their mental health (22) and may also
have significant negative effects on the cognitive, social and
physical development of their children (23). The evidence
for an association between breastfeeding and PPD is,
however, unclear (23,24).
Postpartum weight retention is a predictor for future
overweight and obesity (25) and is associated with obesity-
related illnesses, such as type 2 diabetes mellitus and
cardiovascular disease (26). Breastfeeding may promote
weight loss due to lactation (27), but there is a lack of strong
evidence to support this hypothesis (28).
We conducted this review to summarise the literature
and explore the relationship of breastfeeding and its
duration with long-term (breast carcinoma, ovarian carci-
noma, osteoporosis and type 2 diabetes mellitus) and short-
term (lactational amenorrhoea, postpartum depression,
postpartum weight change) maternal health outcomes.
Outcomes for review were selected during an expert
meeting at the World Health Organization (October
2014) that was reviewing the impact of breastfeeding on
maternal and child health.
METHODS
A search strategy (Box 1) was developed and reviewed by
all authors. Medical Subject Heading (29) terms and
keywords were used in various combinations. We searched
published literature from PubMed, Cochrane Library and
CABI databases to identify studies examining the effect of
type and duration of breastfeeding on maternal health
outcomes. We conducted the search in February 2015. No
language or date restrictions were employed in the elec-
tronic search.
Two review authors (RC and BS) screened the titles and
abstracts independently to identify potentially relevant
citations. These review authors retrieved the full texts of
all potentially relevant articles and independently assessed
the eligibility of the studies using predefined inclusion
criteria. We extracted data from all articles found to be
relevant by both authors. Any disagreements or discrepan-
cies between reviewers were resolved by discussion and if
necessary by consulting a third author (JSM). In addition to
the electronic search, we searched reference lists of the
articles identified. We used Web-based citation index for
citing manuscripts of these identified articles.
We identified four recent systematic reviews addressing
the following outcomes: ovarian carcinoma (30), type 2
diabetes mellitus (31), postpartum depression (32) and
postpartum weight change (33). We planned to update
these reviews and provide new quantitative estimates of
breastfeeding on these health outcomes. For other maternal
health outcomes, that is breast carcinoma, osteoporosis and
lactational amenorrhoea, we planned for new reviews.
Box 1. Search strategy for breastfeeding & maternal health
1 Breastfeeding OR Breast Feeding OR Lactation
OR Human Milk OR Breast Milk
2 Women OR Maternal OR Postpartum OR puer-
peral OR postnatal OR Birth OR gestation
3 Diabetes OR (Breast AND (Carcinoma OR carci-
noma OR tumor OR malignancy)) OR (Ovarian
OR Ovary AND (Carcinoma OR carcinoma OR
tumor OR malignancy)) OR (depression OR Blues
OR psychosis) OR (Amenorrhea OR Contracep-
tion) OR (Osteoporosis OR Bone mineral density)
OR Weight OR BMI OR body mass index
4 (Addresses[ptyp] OR Autobiography[ptyp] OR
Bibliography[ptyp] OR Biography[ptyp] OR pub-
med books[filter] OR Case Reports[ptyp] OR
Congresses[ptyp] OR Consensus Development
Conference[ptyp] OR Directory[ptyp] OR Dupli-
cate Publication[ptyp] OR Editorial[ptyp] OR
Festschrift[ptyp] OR Guideline[ptyp] OR In
Vitro[ptyp] OR Interview[ptyp] OR Lectures
[ptyp] OR Legal Cases[ptyp] OR News[ptyp] OR
Newspaper Article[ptyp] OR Personal Narratives
[ptyp] OR Portraits[ptyp] OR Retracted Publica-
tion[ptyp] OR Twin Study[ptyp] OR Video-Audio
Media[ptyp])
5 #1 AND #2 AND #3
6 #5 NOT #4
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Inclusion criteria
Weselected all observational studies (prospective/retrospec-
tive cohort and case–control), randomised controlled trials
(RCTs), including cluster randomised trials, and quasi-
experimental trials which examined the impact of duration
and type of breastfeeding on maternal health outcomes. For
articles notwritten in English, we attempted to get anEnglish
abstract. If it was not available, the article was excluded.
Abstraction, summary measure, breastfeeding categories
and analysis
We abstracted data using a modified Cochrane data
abstraction form. If a study provided separate estimates
for hospital- and community-based populations, then the
outcome estimates were pooled separately. We used odds
ratios (ORs), both adjusted and unadjusted, as our outcome
estimate for breast and ovarian carcinoma. Relative risk
(RR) was used as the outcome estimate for lactational
amenorrhoea. To examine the effect on breast and ovarian
carcinoma, breastfeeding was categorised into ever breast-
fed vs. never breastfed and also by breastfeeding duration,
that is breastfed less than six months vs. not breastfed;
breastfed 6 to 12 months vs. not breastfed; and breastfed
>12 months vs. not breastfed. For lactational amenorrhoea,
we used exclusive, predominant, partial, any and no
breastfeeding as the categories (Table A1). Standardised
mean differences in bone mineral density between highest
and lowest breastfeeding duration categories were used for
osteoporosis outcome. A narrative approach was used to
summarise the studies for postpartum weight change as the
studies were very heterogeneous.
We performed meta-analysis with Stata 11.2 software
(StataCorp, College Station, TX, USA). We calculated the
pooled estimates of the outcome measures from the odds
ratios (ORs), relative risks (RRs), standardised mean differ-
ences (SMDs) and 95% confidence intervals (CIs) of the
individual studies by inverse variance or DerSimonian and
Laird method in Stata (34). High heterogeneity was defined
byeither a lowp-value (<0.10)or I2 value greater than60%. In
cases of high heterogeneity, the random-effects model was
used and causes were explored by conducting subgroup
analysis and meta-regression. Subgroup analyses were car-
ried out based on breastfeeding categories (ever vs never, less
than sixmonths vs never, 6–12 months vs never, >12 months
vs never). Among the ever vs never breastfeeding category,
subgroup analyses were carried out based on sample size
(<500, 500–1499, ≥1500), individual study setting (i.e. high-
income country (HIC) or low- and middle-income country
(LMIC) (35)), study design (cohort, case–control), mean age
of diagnosis (≤49 years, >49 years), adjustment for parity
(fine adjustment, i.e. adjustment according to each parity
number measured as 0, 1, 2, 3, 4+; crude adjustment, i.e.
groupwise adjustment measured as 0, 1–3, 4+ children; and
no adjustment), control for confounding (thorough, i.e.
controlled for all potential socio-demographic and repro-
ductive factors such as age, income, ethnicity, parity, contra-
ceptive use, family history of carcinoma, menopausal
status and smoking; partial, i.e. only partially controlled for
potential socio-demographic and reproductive factors; and
none) and quality of study (adequate, i.e. study had none or
one among selection bias, measurement bias, attrition (20%)
and confounding bias; inadequate) (36). We also evaluated
the presence of publication bias in the extracted data for the
primary outcome using Begg’s test or Egger’s test or funnel
plots (37).
RESULTS
We screened the 12 071 titles identified. Of these, after
reviewing abstracts of 1501 articles, we selected 341 for full-
text review. We identified 163 articles for inclusion in our
final database (Fig. 1). Among these, 100 studies examined
the impact of breastfeeding on breast carcinoma, 40 studies
on ovarian carcinoma, 12 studies on lactational amenor-
rhoea, five studies on postpartum weight change and six
studies on osteoporosis. We did fresh meta-analysis for
breast carcinoma, ovarian carcinoma, osteoporosis and
lactational amenorrhoea and updated the review on post-
partum weight change. No new studies subsequent to the
existing reviews on type 2 diabetes mellitus and postpartum
depression (31,32) were found to be eligible for inclusion.
Effects of breastfeeding on long-term maternal health
outcomes
Breast carcinoma
We identified 98 estimates (38–135) of the association
between ever breastfeeding and breast carcinoma risk
(Tables 1 and A2). Ever breastfeeding was associated with
22% (OR 0.78, 95% CI 0.74–0.82) (Fig. 2) reduction of
breast carcinoma risk compared with never breastfeeding.
Compared with no breastfeeding, breastfeeding for less
Figure 1 : Prisma Flow chart.
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than six months (39 estimates) and breastfeeding for 6–
12 months (36 estimates) were associated with 7% (OR
0.93, 95% CI 0.88–0.99) and 9% (OR 0.91, 95% CI 0.87–
0.96) risk reduction of breast carcinoma, respectively. We
found that mothers who breastfed for >12 months com-
pared with those who did not breastfeed had a 26% lower
risk of developing breast carcinoma (50 studies; OR 0.74,
95% CI 0.69–0.79), and when restricted to high-quality
studies, only (41 studies) breastfeeding >12 months was
associated with 23% lower risk of developing breast
carcinoma (OR 0.77, 95% CI 0.72–0.83) (not shown in
Table 1). There was, however, an indication of publication
bias. Asymmetry was observed in funnel plot when
inspected visually. Both Egger’s test (p bias <0.001) and
Begg’s test (p bias <0.001) showed statistically significant
findings.
Subgroup analysis of the effects of ever breastfeeding on
risk of breast carcinoma among studies conducted in high-
income countries, with large sample sizes (>1500), of
cohort design, with thorough control of confounding
factors and adequate quality showed a smaller breast
carcinoma risk reduction. Studies where fine adjustment
for parity was made showed a smaller effect of breast-
feeding on breast carcinoma risk reduction (OR 0.92, 95%
CI 0.88–0.96) compared with studies where crude adjust-
ment or no adjustment was made. A restricted analysis
including parous women in the fine adjustment subgroup
showed a risk reduction of 7% for breast carcinoma (OR
0.93, 95% CI 0.89–0.97; 14 estimates) (not shown in
Table 1).
Ovarian carcinoma
Pooled results from 41 estimates (65,69,136–173) showed
that mothers who ever breastfed their children had a 30%
reduction in the risk of ovarian carcinoma, when compared
with those who never breastfed (OR 0.70, 95% CI 0.64–
0.77) (Tables 2 and A3; Fig. 3). The risk of ovarian
carcinoma was 17% lower among women who had breast-
fed for less than six months when compared with those who
did not breastfeed (OR 0.83, 95% CI 0.78–0.89). The risk of
ovarian carcinoma among mothers who breastfed for 6–
12 months was 28% lower (OR 0.72, 95% CI 0.66–0.78; 19
Table 1 Risk of breast carcinoma by breastfeeding duration and by subgroup
Number
of estimates
Pooled odds ratio and
95% confidence interval p-value I2 (%)
Breastfeeding category
Ever vs. Never 98 0.78 (0.74; 0.82) <0.001 71.9
<6 months vs. Never 39 0.93 (0.88; 0.99) 0.05 59.1
6–12 months vs. Never 36 0.91 (0.87; 0.96) <0.001 22.5
>12 months vs. Never 50 0.74 (0.69; 0.79) <0.001 62.2
Subgroup analysis (Ever vs. Never)
Number
of estimates
Pooled odds ratio and
95% confidence interval p-value I2 (%)
Meta-regression
p-value
Study size
<500 participants 15 0.50 (0.37; 0.66) <0.001 59 0.009
500–1499 participants 31 0.74 (0.66; 0.83) <0.001 66.7
≥1500 participants 52 0.83 (0.80; 0.88) <0.001 71.7
Setting
High income 72 0.81 (0.77; 0.85) <0.001 72.5 0.206
Lower mid-income 26 0.66 (0.56; 0.77) <0.001 68.3
Study design
Cohort 12 0.85 (0.83; 0.87) <0.001 53.5 0.705
Case–control 86 0.77 (0.72; 0.81) <0.001 73.3
Mean age
≤49 28 0.78 (0.71; 0.87) <0.001 73.5 0.369
>49 28 0.68 (0.60; 0.78) <0.001 84.8
Adjusted for parity
Fine adjustment 19 0.92 (0.88; 0.96) <0.001 54.8 0.037
Crude adjustment 19 0.86 (0.81; 0.90) <0.001 23.2
No adjustment 60 0.73 (0.68; 0.79) <0.001 77.4
Control for confounding
Thorough 40 0.82 (0.77; 0.87) <0.001 68 0.479
Partial 25 0.77 (0.69; 0.87) <0.001 71.2
None 33 0.74 (0.68; 0.81) <0.001 76.1
Quality of study
Adequate 66 0.81 (0.78; 0.85) <0.001 62.6 0.750
Inadequate 32 0.70 (0.61; 0.80) <0.001 81.6
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estimates) when compared with women who had not
breastfed. The highest risk reduction was observed among
women who breastfed for more than 12 months, in whom
the risk of ovarian carcinoma was 37% lower than among
women who had not breastfed (OR 0.63; 95% CI 0.56–0.71;
29 estimates). The effect size was slightly less (OR 0.65, 95%
CI 0.57–0.73), when the analyses were restricted to high-
quality studies (29 estimates). There was no evidence of
publication bias in Egger’s test or Begg’s test (p bias >0.1) in
either of the analyses.
In subgroup analysis, studies with sample sizes of more
than 1500 showed a significant protection of 24% from
NOTE: Weights are from random effects analysis
Overall  (I-squared = 71.9%, p = 0.000)
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Figure 2 Effect of ever breastfeeding vs. no breastfeeding on risk of breast carcinoma.
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ovarian carcinoma (OR 0.76, 95% CI 0.69–0.84). This
effect size was reduced compared to studies with smaller
samples (OR 0.67, 95% CI 0.53–0.84). Studies in HICs
also showed a significant but reduced effect (OR 0.74, 95%
CI 0.68–0.80) compared with studies in LMICs (OR 0.48
95% CI 0.29–0.77). Lower quality studies showed a higher
risk reduction for ovarian carcinoma (OR 0.63, 95% CI
0.58–0.68) than higher quality studies (OR 0.72, 95% CI
0.65–0.80). Studies where fine adjustment for parity was
made showed a modest but still significant (OR 0.80, 95%
CI 0.75–0.86) reduction in risk of ovarian carcinoma
compared with studies where no or crude adjustment for
parity was made. In an analysis restricted to parous
women in the fine adjustment subgroup, the effect was
further attenuated (OR 0.82, 95% CI 0.75–0.89) (not
shown in Table 2).
Osteoporosis
A total of six studies (174–179) were identified (Table 3).
Two studies were from LMICs (174,178) and four studies
from HICs (175–177,179). Bone mineral density (BMD)
was generally measured at two sites, that is femoral neck
and distal radius. For femoral neck, four studies (175,177–
179) were identified with small sample size (total 489
women). The pooled effect suggests that breastfeeding had a
nonsignificant effect on femoral neck bone mass. With
respect to distal radius, four studies (174–177) were iden-
tified and the results were heterogeneous. The largest
(n = 963) study (176) did not observe any association,
whereas Chowdhury et al. (174) (n = 400) reported a
negative effect of breastfeeding on bone mineral density.
Overall, there was no clear evidence of an effect of
breastfeeding on osteoporosis.
Diabetes
A recent systematic review by Aune reported a reduced risk
of type 2 diabetes (RR 0.68 95% CI: 0.57–0.82) with longer
duration of lifetime breastfeeding compared with shorter
durations. A one-year increase in the total lifetime duration
of breastfeeding was associated with 9% protection (RR
0.91, 95% CI: 0.86–0.96) against the presence of type 2
diabetes in the mothers. No new studies were found
Table 2 Risk of ovarian carcinoma by breastfeeding duration and by subgroup
Number of
estimates
Pooled odds ratio and
95% confidence interval p-value I2 (%)
Breastfeeding category
Ever vs. Never 41 0.70 (0.64; 0.77) <0.001 70.0
<6 months vs. Never 20 0.83 (0.78; 0.89) <0.001 3.0
6–12 months vs. Never 19 0.72 (0.66; 0.78) <0.001 22.0
>12 months vs. Never 29 0.63 (0.56; 0.71) <0.001 51.8
Subgroup analysis
(Ever vs. Never)
Number of
estimates
Pooled odds ratio and
95% confidence interval p-value I2 (%)
Meta-regression
p-value
Study size
<500 participants 7 0.67 (0.53; 0.84) 0.001 2.8 0.241
500–1499 participants 12 0.59 (0.47; 0.74) <0.001 74.9
≥1500 participants 22 0.76 (0.69; 0.84) <0.001 70.9
Setting
High income 35 0.74 (0.68; 0.80) <0.001 64.0 0.007
Lower mid-income 6 0.48 (0.29; 0.77) <0.001 77.1
Study design
Cohort 5 0.87 (0.78; 0.98) 0.02 0.0 0.136
Case–control 36 0.68 (0.61; 0.75) <0.001 71.6
Mean age
≤49 10 0.70 (0.64; 0.77) <0.001 70 0.744
>49 24 0.71 (0.63; 0.80) <0.001 77
Adjusted for parity
Fine adjustment 16 0.80 (0.75; 0.86) <0.001 56 0.231
Crude adjustment 4 0.69 (0.59; 0.81) <0.001 45
No adjustment 21 0.67 (0.58; 0.77) <0.001 72
Control for confounding
Thorough 14 0.76 (0.67; 0.85) <0.001 64.9 0.419
Partial 15 0.66 (0.55; 0.81) <0.001 73
None 11 0.72 (0.65; 0.78) <0.001 50.5
Quality of study
Adequate 27 0.72 (0.65; 0.80) <0.001 71 0.505
Inadequate 14 0.63 (0.58; 0.68) <0.001 54.7
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subsequent to the systemic review by Aune et al. in 2013
(31).
Effects of breastfeeding on short-term maternal health
outcomes
Lactational amenorrhoea
We identified 12 studies (173,180–190) that examined the
association between breastfeeding and lactational amen-
orrhoea (Table 4). Four studies (180,182,185,188) did not
provide either RR or OR. They reported that exclusive
compared to mixed feeding, or longer duration of any
breastfeeding, was associated with an increased mean or
median duration of lactational amenorrhoea. The remain-
ing studies provided data from which the following
estimates were derived: the probability of continued
lactational amenorrhoea at six months postpartum was
23% higher (RR 1.23, 95% CI 1.07–1.41; three studies) for
exclusive or predominant breastfeeding compared to no
breastfeeding, and 21% higher (RR 1.21, 95% CI 1.01–
1.25; five studies) (Table 4) when compared to partial
breastfeeding. We found no evidence of publication bias.
Postpartum depression
A recent systematic review conducted by Dias et al.
reported that pregnancy depression predicts a shorter
breastfeeding duration, but evidence is unclear on whether
breastfeeding mediates the association between pregnancy
and postpartum depression. No new studies were found
subsequent to the systemic review conducted by Dias and
Figueiredo in 2015 (32).
Figure 3 Effect on ever vs. never breastfeeding on risk of ovarian carcinoma.
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Postpartum weight change
We updated the systematic review by Neville et al. (33) by
including 5 additional studies (Table 5) (191–195). In the
review by Neville et al., the majority of identified studies
reported little or no association between breastfeeding and
weight change. Of those five studies, three studies were
performed in low- and middle-income countries, one was
performed in high-income country, and one was multicen-
tre study (Brazil, Ghana, India, Norway, Oman, USA). In
studies performed in low- and middle-income countries, we
have not found any potential differential effect for breast-
feeding and postpartum weight loss response as a function
of countries being low to middle and high income. Two of
the five additionally identified studies (194,195) reported a
significant reduction in postpartum weight with breastfeed-
ing. Sarkar and Taylor (191) in a cross-sectional study in
Bangladesh revealed that body weight of mothers was
negatively correlated with 1–12 and 13–24 months of
lactation after controlling for height, education and food
consumption. Stuebe et al. (192) showed that women who
exclusively breastfed for greater than six months had the
lowest BMI at 3 years postpartum as well as the lowest
postpartum weight retention at 3 years compared with
women who never exclusively breastfed. A multicentre
study showed that lactation intensity and duration
explained little variation in weight change patterns (193–
195). Overall, the role of breastfeeding on postpartum
weight change remains unclear.
DISCUSSION
The aim of this review was to systematically examine the
effect of breastfeeding on important maternal health
outcomes.
The risk of developing breast carcinoma was reduced by
26% among women who cumulatively breastfed for more
than 12 months, compared with women who did not breast
feed.
Previous reviews suggested that breastfeeding was not
strongly related to risk of breast carcinoma (196,197) or
found a small but statistically significant protective asso-
ciation (198–200). Our meta-analysis findings are compa-
rable with but suggest a higher level of protection than
that found by the Collaborative Group on Hormonal
Factors in Breast Carcinoma (201). In this pooled analysis
of approximately 50 000 carcinoma cases from 47 studies
in 30 countries around the world and after adjustment for
confounders including parity and exclusion of nulliparous
women, the authors estimated that the risk of invasive
breast carcinoma decreased by 4.3% for every 12 months
of breastfeeding (201). However, one of the challenges of
comparing studies on cumulative breastfeeding duration
and determining the effect on breast carcinoma risk is the
lack of a standard protocol for grouping the lifetime
number of months of breastfeeding for analysis and the
adjustment of parity. Lifetime duration of breastfeeding is
related to the number of children breastfed, that is parity
and the duration of breastfeeding for each child. Our
Table 4 Effect of breastfeeding on probability of lactational amenorrhoea
Breastfeeding category
No. of
Estimates Ref. no
Probability of lactational
amenorrhoea
RR (95% CI)
p-value (test of
heterogeneity)
Exclusive or Predominant BF vs. No BF 03 176,180,185 1.23 (1.07–1.41) 0.34
Exclusive or Predominant BF vs. Partial BF 05 174,178,179,182,184 1.21 (1.01–1.25) 0.08
Any BF (exclusive or predominant or partial BF) vs. No BF 04 181,185,186,190 1.14 (0.92–1.40) 0.01
Table 3 Association between breastfeeding and bone mineral density
First author name (year)
Mean  SD: BMD
highest BF group (g/cm2)
Mean  SD: BMD
lowest BF group (g/cm2) Pooled SMD (95% CI) of BMD
Distal Radius
Chowdhury (2002) (174) 0.49  0.11 0.61  0.08 Fixed effect 0.132 (0.26 to 0.003)
Hawker (2002) (176) 0.477  0.05 0.474  0.03
Henderson (2000) (177) 0.564  0.06 0.601  0.05 Random effect 0.490 (1.357 to 0.376)
Drinkwater (1991) (175) 0.541  0.07 0.545  0.05
Femoral Neck
Henderson (2000) (177) 0.835  0.11 0.847  0.12 Fixed effect 0.142 (0.426 to 0.142)
Lenora (2009) (178) 0.603  0.13 0.613  0.12
Wiklund (2012) (179) 0.96  0.11 0.97  0.11
Drinkwater (1991) (175) 0.95  0.05 1.01  0.10
BMD, bone mineral density; SD, standard deviation; SMD, standardised mean difference.
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results showed that when controlled for parity, breast-
feeding independently contributed to a modest but signif-
icant risk reduction for breast carcinoma. The risk
reduction for breast carcinoma was 8% among ever
breastfed mothers when finely adjusted for parity, while
it was 22% when all studies were pooled together. Even
when our analysis was restricted to only parous women,
finely adjusted for parity, ever breastfeeding was associ-
ated with a 7% reduction in risk of breast carcinoma
compared with never breastfeeding. Longer duration of
breastfeeding (>12 months) was associated with more
protection of breast carcinoma than shorter duration of
breastfeeding (breastfeeding <6 and 6–12 months) when
compared to never breastfeeding. Even when our analysis
was restricted to studies with adequate quality, breastfeed-
ing >12 months showed more protection against breast
carcinoma. Possible biological mechanisms include that
protection may occur through parity-specific changes in
levels of circulating hormones such as estradiol, prolactin
and growth hormone, as each of these has been associated
with breast cancer risk (202), or that the parous mammary
gland may contain epithelial cells with a more differenti-
ated and less proliferative character which are less
susceptible to transformation (203).
Breastfeeding by women for more than 12 months was
also associated with a 35% reduction in ovarian cancer,
compared with women who had not breastfed. The protec-
tive effect was less in women who had only ever breastfed
Table 5 Overview of studies which examined the association between breastfeeding and postpartum weight change
S. No. Author Name (year) Location Age Association between Breastfeeding and Weight Change
Covariates included
in analyses
1 Monteiro et al.
2013 (194)
Brazil <24 years – 48.2%
>24 years – 51.8%
For women within 2-year postpartum period,
each breastfeeding score point increases
an average postpartum loss of 70 g (p = 0.002)
Sanitary condition of household
Social programs of income transfer
Type of delivery
Prepregnancy weight
2 Onyango et al.
2011 (193)
Brazil, Ghana, India,
Norway, Oman, USA
Brazil 28.3 (6.3) Lactation intensity and duration explained little
of the variation in weight change patterns
Maternal age
Ghana 30.8 (3.9) BMI at 14 days
India 29.0 (3.5) Parity
Norway 30.8 (4.3) Delivery mode
Oman 27.7 (5.0) Infant birthweight
USA 31.5 (4.5) Sex
3 Samano et al.
2013 (195)
Mexico 18.8 years Among both adult and adolescent
mothers, those who practised EBF
lost more weight than those who
did not practise EBF (2.9 kg,
interquartile range, 5.7 to 0.8 kg,
vs 1.8 kg, interquartile range
2.8 to 2.2 kg)
Pregestational weight
Marital status
Education
Delivery mode
Duration of
Lactation
Mean Body
Weight (kg)
Mean BMI
(kg/m2)
4 Sarkar et al.
2005 (191)
Bangladesh 18–40 years Nonlactating 44.3 19.4 Age
Height
Education
<12 42.48 18.86
12–24 42.96 18.85
25–36 43.32 19.11
37–48 43.47 19.29
49–60 44.11 19.36
5 Stube et al.
2010 (192)
East Massachusetts,
USA
Ghana:
30.8 (3.9)
Months of
Lactation
BMI kg/m2
(95% CI)
Prepregnancy BMI
0 26.1 (25.4–26.9) Parity
0–3 25.3 (24.6–26.0) Family history of diabetes
3–6 25.5 (24.9–26.2)
6–12 25.8 (25.2–26.3)
>12 25.4 (24.8–26.0)
Months of
Lactation
Wt. retention
kg mean (95% CI)
0 2.5 (0.6–4.3)
0–3 0.2 (1.6–2.0)
3–6 0.9 (0.8–2.6)
6–12 1.3 (0.1–2.8)
>12 0.4 (1.2–1.9)
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(for any duration) ranging from 30% in an unadjusted
analysis to 18% when the analysis was restricted to ever
breastfeeding parous women (finely adjusted for parity). A
number of physiological mechanisms may account for the
protective effect of breastfeeding against ovarian cancer
through modulating ovarian cycle length (204), and there-
fore, parity is an important confounder. Longer duration of
breastfeeding suppresses ovulation longer and causes sup-
pression of gonadotropins, resulting in depressed produc-
tion of plasma estradiol, considered to be a potential causal
mechanism of ovarian cancer when present at high levels
(205). However, breastfeeding must also have an indepen-
dent effect to explain the estimated reduction in ovarian
cancer when parity is adjusted for.
There did not appear to be a significant effect of
breastfeeding on the risk of osteoporosis. Calcium metabo-
lism and bone metabolism are substantially altered during
pregnancy and lactation, and high calcium demand during
lactation makes women more prone to bone resorption and
subsequent osteoporosis. There was no evidence of such
risk, and it has been suggested that during lactation,
oestrogen imposes minor inhibitory effect on periosteal
bone formation and permits periosteal expansion which
increases bone size after weaning (206).
Available review suggests that longer duration of breast-
feeding reduces risk of development of type 2 diabetes
mellitus by 32%, and in linear dose–response analyses, there
was a 9% reduction in relative risk for each 12-month
increase in lifetime duration of breastfeeding. Our review
shows that exclusive or predominant breastfeeding during
the first six months postpartum was associated with longer
periods of amenorrhoea. Less intensive breastfeeding, cap-
tured under ‘any or partial breastfeeding’, offers less clear
benefit. This finding is biologically plausible. Breastfeeding
suppresses the resumption of ovarian activity after child-
birth and is thus associated with a period of infertility.
Exclusive breastfeeding and predominant breastfeeding are
associated with a higher frequency of suckling than other
patterns of breastfeeding. Frequent suckling inhibits gona-
dotropin-releasing hormone and decreases the release of
luteinising hormone and follicle-stimulating hormone
(207), thus preventing early return of menses.
The association between breastfeeding and postpartum
weight change remains uncertain. Factors such as age,
gestational weight gain and prepregnancy weight confound
such analyses (208,209). As prepregnancy weight and
gestational weight gain were found to be strong determinant
factors of postpartum weight change, future research should
include the preconception period with continued monitor-
ing into the postpartum period to capture the true trajectory
of weight change. Even though BF may not lead to
postpartum weight loss under ‘natural’ conditions, it
remains unknown whether women who wish to lose weight
intentionally in the postpartum period are more likely to be
successful at doing so if they are vs. if they are not
breastfeeding.
Although our original review plans included exploring
the associations between breastfeeding and the risk of
maternal postpartum depression and type 2 diabetes, we
were unable to identify new studies following the reviews
published in 2015 (31) and 2013 (32). The evidence
suggests that the relationship between breastfeeding and
postpartum depression is lacking.
The range of the maternal outcomes examined and the
various categories of breastfeeding exposures that we
considered are important strengths of this review. Despite
the expanded scope of review, other important maternal
health outcomes such as maternal hypertension and
cardiovascular disease were not addressed and should be
considered in future research and reviews. Also important
was the attempt to look for dose–response relationships
and the evaluation of heterogeneity and publication biases.
However, some limitations should be acknowledged. We
have pooled data from many observational studies that are
prone to be affected by biases such as in recall or due to
selection. Some studies did not control for or collect
information on potential confounders that could have
affected the association between breastfeeding and the
outcome of interest. For postpartum weight change, we
were constrained to take a narrative approach to present
the outcomes because of the heterogeneous nature of the
studies. In cases of significant heterogeneity in study
results, we have performed post hoc subgroup analysis
and meta-regression and have used the random-effects
model. But in some cases even within subgroups, there
was significant heterogeneity which suggests some other
unidentified factors causing such heterogeneity. Although
the meta-regression seemed to explain around 80% of the
heterogeneity for breast and ovarian carcinoma, we need
to acknowledge the limitation of post hoc subgroup
analysis.
CONCLUSION
Our meta-analysis shows that women who had ever
breastfed and who breastfed for longer duration have a
lower risk of breast and ovarian carcinoma and also
type 2 diabetes mellitus. Exclusive or predominant breast-
feeding during the first six months postpartum prolongs
lactational amenorrhoea. We found no evidence of a clear
association between breastfeeding and bonemineral density,
maternal depression or postpartum weight change.
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APPENDIX
Table A1 Breastfeeding exposures (WHO definitions) (210)
Exposure Category Permitted to Receive
Exclusive breastfeeding  Breast milk from mother or wet nurse or expressed breast milk
 No other liquids or solids except vitamin drops or syrups, mineral
supplements, or prescribed medicines
Predominant breastfeeding  Breast milk from mother or wet nurse or expressed breast milk
 Water and water-based drinks
 No food-based fluid with the exception of fruit juice and sugar water
 Vitamin drops or syrups, mineral supplements, or prescribed medicines
Partial breastfeeding  Breast milk from mother or wet nurse or expressed breast milk
 Any other liquids or nonliquids, including both milk and nonmilk products
Any breastfeeding  Breast milk from mother or wet nurse or expressed breast milk
 Includes children exclusively, predominantly, fully and partially breastfed
No breastfeeding  Formula and/or animal’s milk
 No breast milk
Table A2 Summary of studies included in breast carcinoma
Estimates Studies Ref. No. Design Country Quality
Ever vs. Never
98 98 38–135 Cohort 12 HIC 72 AQ 66
Case–control 86 LMIC 26 IQ 32
<6 months vs. Never
39 39 39,40,42,48,51,53,56,57,59,60,62,66,69,71,
74,78,80,83,85,88,92,93,95,96,98,99,105,107,
110,112,114–116,119–121,135,211,212
Cohort 7 HIC 33 AQ 32
Case–control 32 LMIC 6 IQ 7
6–12 months vs. Never
36 36 39,42,48,51,56,57,59,60,62,63,66,69,71,74,78,
80,83,85,88,93,95,96,98,99,105,107,110,112,
114–116,119–121,135,211
Cohort 7 HIC 31 AQ 31
Case–control 29 LMIC 5 IQ 5
>12 months vs. Never
50 50 38–40,42,48,51,56,57,59–67,69,71,74,78–80,82,83,85,88,93,95,96,98,99,101,105,107,110,112–
116,119–121,125–127,131,135,211
Cohort 8 HIC 43 AQ 41
Case–control 42 LMIC 7 IQ 9
HIC, high-income country; LIC, low-income country; AQ, adequate quality; IQ, inadequate quality.
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Table A3 Summary of studies included in ovarian carcinoma
Estimates Studies Ref. No. Design Country Quality
Ever vs. Never
41 40 65,69,136–173 Cohort 5 HIC 35 AQ 25
Case–control 35 LMIC 5 IQ 15
<6 months vs. Never
20 19 137,138,142,144,147–150,153,155,158,
161,163,165–168,170,173
Cohort 3 HIC 18 AQ 16
Case–control 16 LMIC 1 IQ 3
6–12 months vs. Never
19 18 137,138,142,144,147,148,150,153,155,
158,161,163,165–168,170,173
Cohort 2 HIC 17 AQ 15
Case–control 16 LMIC 1 IQ 3
>12 months vs. Never
29 28 65,69,137–140,142–144,146–148,150,152,153,
155,158,161,163–168,170–173
Cohort 3 HIC 24 AQ 23
Case–control 25 LMIC 4 IQ 5
LIC, low-income country; AQ, adequate quality; IQ, inadequate quality.
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